Industry / Malaysia
Clinical Research Sector Expanding
December 2007 | Company News AlertAfter seeing 70% average annual growth in Malaysia during recent years, US clinical research organisation (CRO) Quintiles has identified the country as a 'key' growth market. Accordingly the firm plans to run even more trials there, particularly in the field of oncology and other high-value therapeutic areas. While BMI expects the Malaysian research sector to expand significantly, it will still lag behind the neighbouring Southeast Asian powerhouses of Singapore and Thailand, which have long been established in this
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
